TriStrata/Mary Kay suit
This article was originally published in The Rose Sheet
Executive Summary
Wilmington, Del. federal court denied Mary Kay's post-trial motions to set aside jury verdict in alpha hydroxy acid patent infringement case, and entered final judgment, with interest, in TriStrata's favor, NeoStrata division reports April 5. Interest on back royalties will bring total amount of the judgment to about $41.4 mil., firm notes. Mary Kay had sought to set aside a 2005 jury verdict, which found the company infringed three TriStrata patents and required direct-seller to pay $26.4 mil. TriStrata won similar AHA patent infringement cases against Valeant Pharmaceuticals, which also failed to overturn a jury verdict (1"The Rose Sheet" March 10, 2004, In Brief)...